Clinical Trials
4 trialsNCT04597125 2026-05-11
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)
Bayer
Phase 4 Active not recruiting
NCT06943495 2025-09-09
PRODIGY-2
CHU de Quebec-Universite Laval
Phase 1 Recruiting
NCT03899467 2024-02-12
The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Completed
NCT02826772 2020-03-17
Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer
Suzhou Kintor Pharmaceutical Inc,
Phase 1 Completed